SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Innophos Holdings, Inc. (NASDAQ: IPHS)

BALA CYNWYD, October 22, 2019 /Access Wire/ – Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Innophos Holdings, Inc. (“Innophos” or “the Company”) (NASDAQ: IPHS) for possible breaches of fiduciary duty and other violations of federal and state law in connection with proposed acquisition of the Company by affiliate of One Rock Capital Partners, LLC (“One Rock”). Under the terms of the agreement, Under the terms of the merger agreement, Innophos holders will receive only $32.00 per share of reach share of Innophos stock they hold.

The investigation concerns whether the Innophos Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether One Rock is underpaying for the Company. The transaction may undervalue the Company and would result in a substantial loss for many Innophos shareholders. For example, the stock was trading over the deal price as recently as April 2019 and the 52-week high is over $37.50 a share.

If you own shares of Innophos stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, or calling toll free 877-534-2590.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.